Zobrazeno 1 - 10 of 83 pro vyhledávání: '"A T Marcel Gosselink"'
1
Akademický článek
Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocol
Autor: Pierfrancesco Agostoni, René J van der Schaaf, Paul Knaapen, Niels van Royen, Adel Aminian, Thomas A Meijers, Koen Teeuwen, Marleen van Wely, Thomas Schmitz, Maurits T Dirksen, Juan F Iglesias, Joseph Dens, Sudhir Rathore, Jan Paul Ottervanger, Jan-Henk E Dambrink, Vincent Roolvink, A T Marcel Gosselink, Renicus S Hermanides, Maarten A H van Leeuwen
Publikováno v: BMJ Open, Vol 10, Iss 7 (2020)
Introduction The radial artery has become the standard access site for percutaneous coronary intervention (PCI) in stable coronary artery disease and acute coronary syndrome, because of less access site related bleeding complications. Patients with c
Externí odkaz: https://doaj.org/article/00e8a19213544cd6be771f8d05fa1a6f
Zobrazit plný text záznamu
2
Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty
Autor: Elvin Kedhi, Vincent Roolvink, J.H.E. Dambrink, A. W. J. van ’t Hof, Harry Suryapranata, Veemal Hemradj, A T Marcel Gosselink, J. P. Ottervanger
Publikováno v: European Heart Journal Acute Cardiovascular Care, 9, 5, pp. 462-468
European Heart Journal Acute Cardiovascular Care, 9, 462-468
Background: The association between chronic beta-blocker treatment and haemodynamics at admission in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention is not well studied. We investigated t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0f4ce760eac8f4f93ccf9bd7bf5fe5
https://doi.org/10.1177/2048872617754277
Zobrazit plný text záznamu
3
Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry
Autor: Peter Damman, A T Marcel Gosselink, Jan Paul Ottervanger, Arnoud W J van 't Hof, Robbert J. de Winter, Jan Henk Dambrink, N.P.G. Hoedemaker, Elvin Kedhi, Evelien Kolkman
Publikováno v: European Heart Journal-Cardiovascular Pharmacotherapy, 5, 3, pp. 127-138
European Heart Journal-Cardiovascular Pharmacotherapy, 5(3), 127-138. Oxford University Press
European heart journal. Cardiovascular pharmacotherapy, 5(3), 127-138. Oxford University Press
European Heart Journal-Cardiovascular Pharmacotherapy, 5, 127-138
AIMS: Proton-pump inhibitors (PPIs) are commonly prescribed in acute coronary syndrome (ACS) patients on antiplatelet therapy. We studied PPI prescription in ACS patients in the era of novel P2Y12 inhibitors and assessed the association between PPI u
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba8c5065701887378b16532544cdb36
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068363025&origin=inward
Zobrazit plný text záznamu
4
Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial
Autor: José P.S. Henriques, Martijn Meuwissen, Bimmer E. Claessen, Jan J. Piek, Jan Baan, Marleen H. van Wely, Kirsten Boerlage-van Dijk, René J. van der Schaaf, A T Marcel Gosselink, Atilla Dirkali, Jeroen Vendrik, E. Karin Arkenbout, Niels van Royen
Publikováno v: Claessen, B E, Henriques, J P S, Vendrik, J, Boerlage-van Dijk, K, van der Schaaf, R J, Meuwissen, M, van Royen, N, Gosselink, A T M, van Wely, M H, Dirkali, A, Arkenbout, E K, Piek, J J & Baan, J 2019, ' Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial ', Catheterization and Cardiovascular Interventions, vol. 93, no. 2, pp. 216-221 . https://doi.org/10.1002/ccd.27814
Catheterization and Cardiovascular Interventions, 93, 216-221
Catheterization and cardiovascular interventions, 93(2), 216-221. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions, 93(2), 216-221. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions, 93, 2, pp. 216-221
Objectives: To investigate the relative performance of treatment with a paclitaxel-eluting balloon (PEB) compared with an everolimus-eluting stent (EES) for in-stent restenosis (ISR) in patients with diabetes mellitus (DM). Background: ISR remains a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2594c6a5dc7b8bea913b80fb866105ed
https://hdl.handle.net/2066/202103
Zobrazit plný text záznamu
5
Complex Large-Bore Radial percutaneous coronary intervention: Rationale of the COLOR trial study protocol
Autor: Juan F. Iglesias, Paul Knaapen, Thomas A. Meijers, Adel Aminian, Maurits T. Dirksen, Koen Teeuwen, Joseph Dens, Niels van Royen, René J. van der Schaaf, Thomas Schmitz, A T Marcel Gosselink, Pierfrancesco Agostoni, Maarten A.H. van Leeuwen, Marleen H. van Wely, Jan-Henk E. Dambrink, Vincent Roolvink, Sudhir Rathore, Jan Paul Ottervanger, Renicus S Hermanides
Publikováno v: BMJ Open, Vol 10, Iss 7 (2020)
Meijers, T A, Aminian, A, Teeuwen, K, van Wely, M, Schmitz, T, Dirksen, M T, van der Schaaf, R J, Iglesias, J F, Agostoni, P, Dens, J, Knaapen, P, Rathore, S, Ottervanger, J P, Dambrink, J-H E, Roolvink, V, Gosselink, A T M, Hermanides, R S, van Royen, N & van Leeuwen, M A H 2020, ' Complex Large-Bore Radial percutaneous coronary intervention: Rationale of the COLOR trial study protocol ', BMJ Open, vol. 10, no. 7, e038042 . https://doi.org/10.1136/bmjopen-2020-038042
BMJ Open, 10, 7
BMJ Open, 10
BMJ Open
IntroductionThe radial artery has become the standard access site for percutaneous coronary intervention (PCI) in stable coronary artery disease and acute coronary syndrome, because of less access site related bleeding complications. Patients with co
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74bff848181497e74675971a87368906
https://doi.org/10.1136/bmjopen-2020-038042
Zobrazit plný text záznamu
7
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
Autor: A T Marcel Gosselink, Elvin Kedhi, Ahmet Adiyaman, Jan-Henk E. Dambrink, Vincent Roolvink, Jan Paul Ottervanger, D. A. A. M. Schellings, Arnoud W J van 't Hof
Publikováno v: Vascular Health and Risk Management
Dirk AAM Schellings,1,2 Ahmet Adiyaman,1 Jan-Henk E Dambrink,1 AT Marcel Gosselink,1 Elvin Kedhi,1 Vincent Roolvink,1 Jan Paul Ottervanger,1 Arnoud WJ van’t Hof,1 1Department of Cardiology, Isala Heart Centre, Zwolle, 2Department of Cardiology, Sli
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd9feb1c17f6ee90c33335cdcf4057b
http://europepmc.org/articles/PMC5123586
Zobrazit plný text záznamu
9
Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention
Autor: Elvin Kedhi, Vicente Sánchez-Brunete, Vincent Roolvink, Arnoud W J van 't Hof, Valentin Fuster, Saman Rasoul, Iwan C. C. van der Horst, Jan-Henk E. Dambrink, Jan Paul Ottervanger, Erik Lipsic, Jan J. Piek, Borja Ibanez, A T Marcel Gosselink, Bart J. G. L. de Smet
Publikováno v: American Heart Journal, 168(5), 661-666. MOSBY-ELSEVIER
American heart journal, 168(5), 661-666. Mosby Inc.
Background beta-Blockers have a class 1a recommendation in the treatment of patients with ST-elevation myocardial infarctions (STEMIs), as they are associated with a reduced mortality, recurrent myocardial infarction, life-threatening arrhythmias, an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7c4653ff6d6dedc05c8b775d80557a
https://doi.org/10.1016/j.ahj.2014.07.015
Zobrazit plný text záznamu
10
Direct Drug-Eluting Stenting to Reduce Stent Restenosis
Autor: Harry Suryapranata, A T Marcel Gosselink, Vincent Roolvink, Samer Somi, Wouter Remkes, Jan-Henk E. Dambrink, Menko-Jan de Boer, Jan Paul Ottervanger, Jan C.A. Hoorntje, Arnoud W J van 't Hof, Saman Rasoul
Publikováno v: JACC: Cardiovascular Interventions. 7:751-758
Objectives The aim was to investigate whether a strategy of direct drug-eluting stent (DES) implantation without pre-dilation is associated with a reduced incidence of restenosis compared with CS with pre-dilation or provisional stenting (PS). Backgr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9bed8eb0a24b1520a9176a391eb002f
https://doi.org/10.1016/j.jcin.2014.02.012
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje